Clinical trial
Understanding Real-World Sequencing Outcomes in Unresectable Hepatocellular Carcinoma (uHCC)
NCT07849660 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding Real-World Sequencing Outcomes in Unresectable Hepatocellular Carcinoma (uHCC)
- Lead sponsor
- Eisai Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 17, 2025
- Completion date
- December 15, 2026
- Enrollment
- 170 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.